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Abstract 
 
Background 
The individual and combined effect of cardiovascular disease (CVD) risk factors (RF) on CVD mortality varies 
between populations. Our aim was to examine this association and its public health impact in Switzerland, a 
country with comparably low CVD mortality. 
 
Methods 
We included 9,853 men and women aged 25-74 years who participated in the Swiss MONICA (MONItoring of 
trends and determinants in CArdiovscular disease) study (1983-1992) and were followed up for survival until 
2008. Adjusted Cox regression was used to calculate CVD mortality hazard ratios (HR). CVD-RF were obesity 
(BMI ≥30 kg/m2), smoking (≥1cig./d), high blood pressure (≥140 or ≥90 mmHg) and total:HDL cholesterol ratio 
(≥5.0). Besides age and sex, models were adjusted for diet, physical activity, educational class, marital status and 
the respective other CVD-RF.  
 
Results 
After adjustment for age and sex, the HR of CVD death was for obesity 1.86 (95% CI 1.50–2.31), for smoking 
1.63 (95% CI 1.32–2.01), for high blood pressure 1.42 (95% CI 1.16–1.73), and for high cholesterol ratio 1.30 
(95% CI 1.06–1.60). Adjustment for other covariates moderately attenuated estimates. CVD-RF had an 
independent and synergistic effect and accounted for 43.0% of population attributable risk. The presence of all 
four compared to zero CVD-RF was associated with a 9.6 years shorter expected survival for a man aged 50.  
 
Conclusions 
Most CVD deaths could be avoided by prevention of four traditional CVD-RF. Reduction of smoking prevalence 
and avoidance of weight gain in the population are the most effective measures. Particular attention should be 
dedicated to persons with multiple CVD-RF.  
 
 
Keywords: Cardiovascular disease mortality; risk factors; MONICA; Switzerland; expected survival; population 
attributable risk
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Introduction  
Worldwide, cardiovascular disease (CVD) is the leading cause of death (1). One of the first studies elaborating 
the joint impact of risk factors (RF) on CVD was the Framingham study (2). These “traditional” RF include 
smoking, obesity, high blood pressure and high cholesterol (2). Framingham and most other studies have focused 
on non-fatal and fatal myocardial infarction (2-6). In contrast, the European SCORE project is based on CVD 
mortality, offering the advantage of a more reliable end-point (7). Another advantage is that SCORE relies on 
traditional RF which are easy to assess and to reproduce. Also, the assessment of these CVD-RF is part of 
routine medical check-ups aiming at an individual risk estimation. 
The population burden associated with CVD-RF substantially vary between countries (3, 7, 8). In order to plan 
targeted prevention measures in a population, it is important to know the respective significance of CVD-RF and 
their combined impact on CVD mortality. For most countries, no specific information is available on the 
population level. The adoption of relative and population attributable risks (PAR) from other countries may be 
problematic because this could lead to inappropriate and ineffective public health measures. As there is no 
representative cohort in this country, there is only little evidence about how (much) traditional CVD-RF 
contribute to mortality in the Swiss population. It is also unknown whether the RF remain predictive for CVD-
mortality after 25 years when they are only measured once at baseline. Commonly used CVD risk calculators are 
based on algorithms from Germany (9), a country with a different CVD-RF and mortality profile (8). In 
Switzerland, CVD mortality has dramatically decreased over the past three decades resulting in internationally 
very low rates (8). Counterintuitively, this apparently occurred without antecedent decrease in CVD-RF (10-12).  
We aimed at determining the impact of four traditional CVD-RF on CVD mortality in Switzerland and their 
population burden in terms of PAR and survival. Now for the first time, this is possible thanks to an anonymous 
record linkage with census and mortality data (see below), allowing a mortality follow-up of over 90% of 
participants of the Swiss MONICA (MONItoring of trends and determinants in CArdiovscular disease) study. 
The combined database includes socio-demographic, behavioural and clinical parameters offering the possibility 
to consider potential confounders and interactions.  
 
 
Methods 
 
Population 
The studied population stems from MONICA, an international multicentre project initiated and coordinated by 
the World Health Organization (WHO) (13) . In Switzerland, the study has been conducted in three waves 
between 1983 and 1992 (14, 15). In this country, the “standard” MONICA age range of 25-64 years at baseline 
has been expanded to 25-74 years. Sampled persons were invited to attend a health examination in their 
community of residence and to complete a self-administered questionnaire. The participation rate varied between 
54 and 78% (16). As in most MONICA centres, it was missed to provide for a mortality follow-up of the general 
population participating in the MONICA risk factors study. This shortcoming could be overcome by an 
anonymous record linkage with the Swiss National Cohort (16, 17). 9,853 (97.8%) of the eligible 10,160 
MONICA participants could be linked with a census, mortality and/or emigration record, for details see (16). 
Details of the study population are given in Table 1.  
 
CVD-RF 
Measurements and blood sampling procedures were described (14, 15). In order to give an impression about the 
graduation of the association with CVD-mortality, we divided each of the four selected CVD-RF into four 
categories. We used the ratio of total cholesterol/HDL-cholesterol because among the available lipid parameters, 
this ratio was the strongest predictor of fatal ischemic heart disease (18). We used the following cut-offs for 
descriptive analyses: <5.0, 5.0-6.4, 6.5-7.9, ≥ 8.0 mmol/l. Blood pressure was categorized according to (19) 
(Table 1). For smoking status we used the categories never, former, light (<20 cig./d), heavy (≥ 20 cig./d). BMI 
was calculated from measured height (cm) and weight (kg) by dividing weight by height squared (kg/m2) and 
into <25, 25-29.9, 30-34.9, ≥35 kg/m2 according to the WHO (20). In order to obtain a sufficient number of 
CVD deaths in the CVD-RF combinations, we additionally collapsed the four categories into two groups (not 
underlined=not at risk vs. underlined=at risk in Figure 1) for analyses hereafter. This categorization 
corresponded to the cut-offs used for CVD risks in most other studies (smoking, blood pressure ≥ 140/90 mmHg, 
cholesterol ratio ≥ 5, obesity).  
 
Covariates 
Among the large number of available questions we selected two (healthy eating und sport) as proxy for a healthy 
lifestyle. Both of them significantly contributed to prediction of CVD-mortality in a model including  “classical” 
RF. and had fewer missing values than other available lifestyle variables. Healthy eating pattern was defined 
when the answers to the question “Which meals do you eat during weekdays?” was “breakfast, lunch and 
dinner”. Sport frequency was obtained with the question: “How often do you do sports?”. Possible answers were: 
“every day, several times per week, once per week, less frequent, never”. Blood pressure treatment was obtained 
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from: “During the past two weeks have you taken drugs in order to lower your blood pressure?” The following 
educational classes were used: i “Mandatory”: elementary schooling (corresponding to completed 8th US grade) 
or less (International Standard Classification of Education, ISCED 1 and 2); ii “Secondary”: vocational training 
or high school (completed 12th US grade; ISCED 3); iii “Tertiary”: technical college, upper vocational or 
university education (ISCED 5) (21). For marital status the categories “single”, “married”, “separated or 
divorced” and “widowed” were available.  
 
End-point 
CVD were defined according to ICD (International Classification of Diseases) revisions 8 (ICD-8: 390-458) and 
10 (ICD-10: I00-I99). In Switzerland ICD-8 was used until 1994 followed by ICD-10 thereafter.  
 
Statistical analyses 
For descriptive analyses, we calculated counts, means and proportions of the variables of interest. We obtained 
hazard ratios (HR) of the four dichotomized CVD-RF variables using Cox proportional hazards models. The 
proportional hazards assumption was tested and appeared to be widely fulfilled. In order to make all models 
comparable, individuals with missing values in any of the covariates (n=9,375) were deleted for this part of the 
analysis. In all models we adjusted for age, sex and survey wave. In a second step, we additionally included 
other covariates; in a third step we additionally adjusted for the respective other CVD-RF variables.  
We generated Cox models including a variable with the number of CVD-RF (0-4) and alternatively, including a 
variable with all possible combinations of smoking, high blood pressure and high cholesterol ratio. 
Unfortunately there were not enough persons being obese without having other CVD-RF to allow robust 
analyses. Therefore combinations with obesity are missing in Figure 2. The results of a Cox model (adjusted for 
age, sex and study wave, four vs. zero risk factors) with all-cause instead of CVD mortality was used to estimate 
mean residual survival. As this requires that all other covariates have to be fixed, we set them to wave 1, male 
sex and age fixed at 50 years at baseline. As the mean survival time is undefined for censored data, we have set 
the maximum observation period to 40 years. The obtained mean residual survival represents the expected 
number of years within this period.  
Population attributable risk (PAR) for each of the four binary risk factors and for their combination was 
calculated as suggested in (22), using the results of a logistic regression model for CVD-mortality including sex, 
age, study wave and the four risk factors as covariates. General descriptive analyses and survival estimations 
were performed with Stata 11 (Stata Corp, Texas, USA, 2009), attributable deaths and mean residual lifetime 
were obtained with R 2.13.0 (The R Foundation for Statistical Computing, 2011). 
 
 
Results  
 
Descriptive analyses 
Characteristics of participants and number of missing values are summarized in Table 1. There were 
substantially more CVD deaths and prevalence of risk factors was higher among men than among women. 
Among men, the proportion of heavy smokers was twice as high and the prevalence of high blood pressure and 
cholesterol ratio was also much higher. Large sex differences were also found for overweight but not for obesity. 
In contrast, differences regarding hypertension treatment, diet, physical activity, education and marital status 
were smaller. Compared to men, women had in average a lower educational class and a higher proportion was 
widowed. Figure 1 shows the four CVD-RF categorized into four severity levels, with the respectively lowest 
category as reference. In none of the four CVD-RF, risk increase for the second lowest category reached 
statistical significance.  The third category showed an increase in relative risk, but the association was only 
statistically significant for cholesterol ratio 6.5-7.9 and obesity class I. The relative risks of the highest categories 
were comparable. The highest relative risks were found for BMI ≥ 35 kg/m2 and heavy smoking.  
 
Multivariable adjusted analyses 
Table 2 shows the HR of CVD-RF obtained from three models with increasing number of covariates. Further 
adjustment for lifestyle factors and socioeconomic status (SES; model two) moderately attenuated the relative 
risk of obesity and smoking, whereas that of high cholesterol ratio and blood pressure remained unchanged. 
Additional adjustment for medication changed the hazard ratio of high blood pressure only marginally: HR 1.29 
(95% CI: 1.05-1.59). Additional adjustment for the respective other CVD-RF increased the relative risk of 
obesity and smoking but decreased that of high cholesterol ratio and blood pressure. In model three, obesity was 
only adjusted for smoking, because high blood pressure and cholesterol are on the leading pathway between 
obesity and death. Including these intermediate risk factors would result in over-adjustment and potential 
difficulties due to multicollinearity. In explorative analyses, obesity remained significantly associated with 
increased CVD death even after additional adjustment for high blood pressure and high cholesterol ratio (HR 
1.57; 1.24-2.00). In addition, the respective PAR adjusted for age and sex is given. In contrast to the HR, PAR 
were higher for high blood pressure and high cholesterol ratio than for obesity and smoking.Based on a logistic 
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regression model including all CVD-RF, the joint PAR (22) was 43.0%. The corresponding PAR for 15 years of 
follow-up was 46.0% (Table A2). 
 
Combination of CVD-RF 
As shown in Figure 2, the combination of high blood pressure with high cholesterol ratio only moderately 
increased the risk compared to high blood pressure alone, suggesting common pathways. In contrast, the 
combination of either high blood pressure or cholesterol ratio with smoking substantially increased mortality 
risk. In fact, as shown in Table A1 (Appendix), the correlation between high cholesterol ratio and high blood 
pressure was somewhat stronger than that between smoking and either high blood pressure or high cholesterol 
ratio. However, the correlation between the CVD-RF was generally weak. Relative risks associated with the 
number of present CVD-RF (irrespective of type) are shown in Figure 3. The risk increase associated with any 
of the CVD-RF was small but statistically significant and the presence of one additional CVD-RF only 
moderately increased the HR. The increase from two to three and from three to four CVD-RF was comparably 
stronger. Corresponding survival curves (Appendix, Figure A1) show the survival probabilities over study time 
for fixed other covariates. Estimations of life expectancy based on the same model for all-cause mortality 
showed that the expected further survival after age 50 in men with none of the four CVD-RF was 35.8 years 
compared to 26.2 years in men with simultaneously all four CVD-RF. 
 
 
 
Discussion  
 
Main results 
This is the first study examining the impact of classical risk factors on CVD mortality in a general population in 
Switzerland. The CVD-RF obesity and smoking markedly increased the risk of cardiovascular death. This 
association remained significant after adjustment for lifestyle factors and SES and other CVD-RF. The impact on 
CVD death of the CVD-RF high blood pressure and particularly of high cholesterol ratio was weaker (Table 2). 
The combination of smoking with any other CVD-RF was particularly hazardous (Figure 2). CVD-RF had a 
synergistic effect when combined: The risk increase between zero and two CVD-RF was weaker than that from 
two to four CVD-RF. The combination of all four CVD-RF resulted in an almost fivefold relative risk increase 
and – for a man aged 50– in a 9.6 years shorter survival. The PAR of 43% arising from all four CVD-RF (Table 
2) suggests that a large proportion of CVD deaths in the population could be avoided. .  
 
Comparison of CVD-RF  
In line with our result, in Australia and Finland, smoking and (central) obesity were more strongly associated 
with CVD and coronary heart disease (CHD) mortality than blood pressure and high cholesterol ratio (23, 24). In 
the Whitehall study (UK), the HR of CVD death for the highest quintile of systolic blood pressure was larger 
than that for smoking and the highest quintile of cholesterol and BMI, the latter three having a similar magnitude 
(25). A similar pattern was found in the Seven Countries Study (US) (26). Using other measures of adiposity 
than BMI could (23) or could not (26, 27) increase predictiveness for CVD. In a study from Chicago (USA), 
CHD death was more strongly associated with a 20 mmHg increase in blood pressure than with smoking or a 
1.03 mmol/L increase in blood cholesterol (28). Similarly, the ESC SCORE calculated an almost threefold CVD 
mortality risk increase from the lowest to the highest blood pressure category, whereas the increase was only 
twofold from the lowest to the highest cholesterol ratio category and for smoking vs. non-smoking (7).  
In the INTERHEART and two European studies, smoking was the most significant CVD-RF of CHD events (4) 
(3, 5). In contrast, in the German MONICA cohort the HR for CHD events of hypertension and cholesterol ratio 
≥5.5 were comparable and were higher than the HR of smoking (6). The Framingham cohort showed similar 
impact of hypertension, smoking and dyslipidemia on CHD events (2).  
 
Adjustment of CVD-RF 
The effect of obesity was only marginally affected by adjustment for lifestyle and SES and remained 
significantly associated with increased mortality after considering high blood pressure and cholesterol ratio 
(Table 2). However, only a part of CHD mortality risk associated with obesity is mediated by these intermediate 
CVD-RF (24, 28). Similar results were also found for non-fatal CVD events (29). In a meta-analysis of 21 cohort 
studies, half of the increased risk of CHD events in overweight and obese persons was explained by higher blood 
pressure and cholesterol levels (30). A substantial proportion of the effect of cholesterol ratio appears accounted 
for by other CVD-RF, suggesting that it could partially be a consequence of smoking and/or obesity. In contrast, 
after full adjustment, the decrease of HR of high blood pressure was small, indicating that this CVD-RF could be 
more independent of other RF. The HR of smoking remained virtually unaffected by adjustment. In fact, 
smokers were less frequently obese than non-smokers (31).  
 
Combination of CVD-RF 
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A study with end-point CVD death found a twofold relative increase for the combination of high blood pressure 
and cholesterol and a threefold relative increase for the combination of high blood pressure and cholesterol with 
smoking (25). This was almost identical to our figures (Figure 2). Similar magnitudes of these CVD-RF (two or 
three of any of them) were found in another study with CVD death as end-point (32). Based on ESC SCORE, the 
10-year risk of CVD death associated with blood pressure, cholesterol and smoking in persons aged 55-65 years 
is ten times higher in the highest than in the lowest risk group (7). The SCORE however compared larger 
extremes of blood pressure (<120 vs. ≥180 mmHg) and cholesterol ratio (<3 vs. ≥7) categories (7). Studies 
analysing fatal and non-fatal CHD resulted in substantially higher HR than ours (3, 5, 6). A study assessing CHD 
mortality risk also found higher relative increases for combinations of CVD-RF (28). When used in combination, 
“traditional” CVD-RF were highly predictive for CVD events (3-6, 23, 25, 27) and only few of them are 
necessary for prediction(23, 27). Additional inclusion of “novel” CVD-RF only minimally added to 
predictiveness (33, 34).  
As found by others (6, 25, 28) the combination of smoking with either high blood pressure or high cholesterol 
ratio resulted in higher HR than the combination of high blood pressure with high cholesterol ratio. This suggests 
more common pathways in the latter two. Nevertheless the increase from zero to four CVD-RF suggests that 
each CVD-RF contributes to CVD-mortality and at least in part independently from the other ones (Figure 3). 
This is also supported by the relatively weak correlations of the considered CVD RF (Table A1). The fact that 
inclusion of obesity in addition to blood pressure and cholesterol ratio increased HR was at odds with a study 
showing that obesity failed to improve fatal and non-fatal CVD risk prediction when blood pressure and lipids 
and history of diabetes were available (27).  
 
Attributable deaths and survival 
Our study showed substantial potential for reduction of CVD deaths by prevention of four CVD-RF (Table 2 
and Figure 3). In the US, a part of the decrease in CVD death between 1980 and 2000 was attributable to 
reduction in cholesterol (24%), blood pressure (20%) and smoking prevalence (12%) (35). Studies with fatal and 
non-fatal CVD-end-points (6) and including a larger number of CVD-RF (3-5) reported attributable risks of 
65%, 85% or more. These larger figures could also relate to the fact that we considered a longer follow-up time. 
In fact, limiting the follow-up time to 15 instead of 25 years in our study  increased the PAR (Table A2, 
appendix). Moreover, in Switzerland, the prevalence of most CVD-RF can be expected to be lower than in other 
countries (8, 36). It is nevertheless surprising that even in “low prevalence” countries such as Switzerland, four 
classical CVD-RF contribute to almost 50% of excess CVD deaths.  
As shown in the Whitehall study, men aged 50 years with the combination of smoking with high blood pressure 
and high cholesterol had in average a 10 years shorter survival than peers without these risk factors (25). This 
was comparable to our result. Similar figures were found in Chicago (9 years in men, 7 years in women) (32) 
and in five large US cohorts (6-10 years) (37). From a public health perspective this is an important finding 
because these risk factors are common in the population. At the same time, CVD-RF are easily detectable in 
clinical practice in a cost-efficient manner. Moreover CVD-RF are modifiable to a large extent and are thus 
widely avoidable.  
 
 
Limitations  
The MONICA participants included in our study had a lower mortality (in particular CVD mortality) than the 
general Swiss population (16). We also had only one assessment of exposure at study entry and could not 
consider changes occurring during follow-up. There was also lack of information on whether individuals with 
CVD-RF followed the advice that has been given upon study inclusion (e.g. cholesterol or blood pressure 
lowering treatment). The information about lifestyle factors relevant for CVD was limited. For example, we had 
only information on diet from a 24h recall and there was no information about the amount of alcohol consumed. 
Moreover, the number of missing answers varied between questions (Table 1). Our estimate of diet and physical 
activity was also rather coarse. However, both contributed to prediction of CVD mortally independently of 
“classical” RF.  Our end-point was limited in the sense that we were restricted to fatal CVD. CVD mortality data 
from death certificates is reliable for young and middle aged persons but may cause misclassification in elderly, 
potentially leading to an underestimation of associated risk (38). Admittedly, the respective significance of risk 
factors could also depend on considered follow-up time (39). As suggested by our separate analyses, it is likely 
that the HR are larger in studies with repeated measurements or shorter follow-up time and that the association 
of a RF with the endpoint “washes out” over time. However, the differences between 25 years (Table 2) and 15 
years of follow-up (Table 2A, Appendix) were relatively small and the overall pattern remained the same.  
The statistical power was too weak to consequently allow separated analyses by age class or by sex. For certain 
strata the small number of CVD deaths precluded robust analyses, e.g. for obese smokers or non-smokers 
without any other CVD-RF. Comparisons of CVD mortality with CHD mortality must be interpreted with 
caution because these outcomes may not follow the same underlying pathways. Finally, limiting to only fatal 
end-ponts may not capture the significance of CVD-RF in its full spectrum.  
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Conclusions and public health implications 
The majority of excess CVD deaths may be prevented by avoiding four risk factors. Smoking prevention is most 
effective, because measures are inexpensive and readily realizable, e.g. by public smoking ban or restricting 
access to cigarettes. Smoking is a particularly high risk when combined with high blood pressure and/or high 
cholesterol ratio. Therefore smokers should be intensively screened and treated at lower thresholds. Large 
prevention potential would arise from reducing weight in obese persons, but this is not realistic. Because 
overweight was not associated with an increased risk, efforts aimed at avoiding weight gain and improving 
health behaviour appear more promising. Avoiding obesity is important because by controlling and treating high 
blood pressure and cholesterol, excess mortality risk can only be decreased but not eliminated. Aggressive 
treatment in persons having only one RF can be disputed. However, because of their synergistic impact on 
mortality, accumulation of three or more risk factors should be avoided. Because it is non-invasive and easily 
conductible, population screening of high blood pressure should be intensified, also in persons without apparent 
RF like obesity or smoking.  
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Figure legends 
 
Figure 1. Age and sex adjusted relative risk of CVD death by severity of CVD-RF, 9,375 participants of the 
Swiss MONICA study, 1983-92, 25-74 years at baseline 
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Reference is the respective lowest category, for the following tables and figures, risk categories were 
dichotomized (underlined: at risk vs. not underlined: not at risk) 
CVD-RF: Cardiovascular disease risk factors; MONICA: MONItoring of trends and determinants in 
CArdiovscular disease 
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Figure 2. Age and sex adjusted relative risk for CVD death by risk factor combination, 9,375 participants of the 
Swiss MONICA study, 1983-92, 25-74 years at baseline 
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Reference category is the first combination (0, 0, 0). BP, blood pressure; HDL-C, high-density lipoprotein 
cholesterol; TC, total cholesterol. 
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Figure 3 Age and sex adjusted relative risk of CVD death by number of CVD-RF, 9,375 participants of the 
Swiss MONICA study, 1983-92, 25-74 years at baseline 
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Reference category is 0. CVD-RF include smoking (≥ 1 cig/d); high blood pressure (≥140 or ≥90); high total 
cholesterol: high-density lipoprotein cholesterol ratio (≥ 5.0); obesity (body mass index ≥30 kg/m2). 
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Table 1. Characteristics (counts, means and proportions) of the study population, Swiss MONICA study, 1983-
92, 25-74 years at baseline 
          
  Men  Women All Missings (n) 
Participants (n) 4969 4884 9853
Mean age (years) 47.0 47.3 47.2
Deaths (n) 
   CVD  280 168 448
   All causes 945 581 1526
CVD-RF 
Smoking 31 
   Never smokers (%) 29.3 51.2 40.1
   Former smokers (%) 33.5 19.7 26.7
   Current light smokers (<20 cig./d, %) 15.0 18.5 16.7
   Current heavy smokers (≥20 cig./d, %) 22.3 10.6 16.5
Blood pressure (systolic / diastolic, mmHg) 21 
   <120/80 (%) 19.5 37.0 28.2
   120–139 or 80–89 (%) 46.0 40.0 43.0
   140–159 or 90-99 (%) 25.0 16.3 20.6
   ≥160 or ≥100 (%) 9.6 6.7 8.2
Total Cholesterol : HDL-Cholesterol 355 
   Mean (ratio) 5.7 4.4 5.1
   <5.0 (%) 41.5 73.2 57.3
   5.0-6.4 (%) 31.7 17.9 24.8
   6.5-7.9 (%) 16.4 6.0 11.2
   ≥8.0 (%) 10.4 2.9 6.7
Body Mass Index (BMI) 16 
   Mean (kg/m2) 26.3 24.8 25.5
   <25 (%) 38.0 59.0 48.4
   25-29.9 (%) 47.7 28.7 38.3
   30-34.9 (%) 12.4 8.9 10.6
   ≥35 (%) 1.9 3.4 2.7
Covariates    
Three main meals daily (%) 64.2 74.4 69.2 3 
Sport 33 
  Every day (%) 3.2 3.9 3.5
  Several times per week (%) 18.6 13.3 16.0
  Once per week (%) 21.4 23.2 22.3
  Less frequent (%) 25.2 19.8 22.5
  Never (%) 31.5 39.9 35.7
Educational class  29 
   Tertiary (%) 23.2 15.3 19.3
   Upper secondary (%) 52.6 44.8 48.7
   Mandatory and secodary (%) 24.2 39.9 32.0
Marital Status 9 
   Single 9.1 9.0 9.0
   Married 84.3 76.4 80.4
   Widowed 1.4 7.0 6.5
   Separated or divorced 5.3 7.6 4.2
Hypertension treatment (%) 11.2 12.7 11.9 117 
 
CVD-RF, Cardiovascular disease risk factors; MONICA, MONItoring of trends and determinants in CArdiovscular disease 
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Table 2. Relative risk of CVD death of selected risk factors increasingly adjusted with three models, 9,375 
participants of the Swiss MONICA study, 1983-92, 25-74 years at baseline 
                
Model (adjustment) 1 (age, sex) 2 (1 + lifestyle, SES)* 3 (2 + other CVD-RF)** 
  PAR (%) HR 95% CI   HR 95% CI   HR 95% CI 
CVD-RF: 
Obesity (BMI ≥30 kg/m2) 11.9 1.86 1.50-2.31 1.75 1.41-2.18 1.81 1.46-2.25 
Smoking (current, light and heavy) 11.1 1.63 1.32-2.01 1.52 1.23-1.89 1.58 1.27-1.96 
High blood pressure (≥ 140 or ≥ 90) 14.5 1.42 1.16-1.73 1.41 1.16-1.73 1.34 1.10-1.64 
High TC:HDL-C ratio (≥ 5.0) 15.3 1.30 1.06-1.60  1.31 1.07-1.61   1.17 0.95-1.44 
 
 
Model 1 (basic): adjusted for age and sex. Model 2 (lifestyle and socioeconomic status): model 1 additionally adjusted for three 
meals per day, physical activity, education, and marital status. The HR of high blood pressure changed to 1.29 (95% CI 1.05–
1.59) after adjustment for blood pressure-lowering medication. Model 3 (cardiovascular disease risk factors): model 2 
additionally adjusted for the other risk factors (obesity: number of cigarettes; smoking: BMI, TC/HDL-C ratio, systolic blood 
pressure; high TC/HDL-C ratio: BMI, systolic blood pressure, number of cigarettes; high blood pressure: BMI, TC/HDL-C ratio, 
number of cigarettes). Obesity was only adjusted for smoking, additional adjustment for blood pressure and cholesterol ratio 
resulted in a HR of 1.57 (95% CI 1.24–2.00). BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; TC, total 
cholesterol; PAR, population attributable risk.  
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Appendix 
 
 
Table A1. Correlation coefficients of the binary and continuous variables, 9,375 participants of the 
Swiss MONICA study, 1983-92, 25-74 years at baseline  
 
          
Variable (binary) Obesity  Smoking  High blood pressure  
High 
TC/HDL-C 
ratio 
Obesity (BMI ≥30 kg/m2) 1 
Smoking (current, light and heavy) 0.07 1 
High blood pressure (≥ 140 or ≥ 90) 0.17 0.05 1 
High TC:HDL-C ratio (≥ 5.0) 0.18 0.07 0.17 1 
 
All p-values are <0.001, calculated with the “Phi” command (correlation of binary variables) of STATA 
 
 
 
          
Variable (cotinuous) BMI Smoking 
Systolic 
blood 
pressure 
TC/HDL-C 
ratio 
BMI (in kg/m2) 1 
Smoking (number of cigarettes)  -0.06 1 
Systolic blood pressure (in mmHg) 0.32 -0.02 1 
TC:HDL-C ratio 0.37 0.13 0.21 1 
 
All p-values are <0.001, calculated with the “Pearson” command of STATA 
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Table A2. Relative risk of CVD death of selected risk factors increasingly adjusted with three models, 
9,375 participants of the Swiss MONICA study, 1983-92, 25-74 years at baseline, follow-up time 
limited to 15 years 
 
    
Model (adjustment): 1 (age, sex) 2 (1 + lifestyle, SES)* 3 (2 + other risk factors)** 
  
PAR 
(%) HR 95% CI   HR 95% CI   HR 95% CI 
CVD-RF 
Obesity (BMI ≥30 kg/m2) 15.0 1.95 1.49-2.56 1.8 1.36-2.37 1.87 1.42-2.46 
Smoking (current, light and heavy) 14.2 1.74 1.33-2.29 1.61 1.22-2.12 1.71 1.29-2.26 
High blood pressure (≥ 140 or ≥ 90) 13.9 1.43 1.10-1.85 1.42 1.10-1.84 1.32 1.02-1.72 
High TC:HDL-C ratio (≥ 5.0) 14.1 1.33 1.02-1.74  1.34 1.02-1.75  1.16 0.88-1.53 
 
 
*Lifestyle, socio-economic status (SES): additional adjustment for three meals per day, physical activity, 
education, marital status. The HR of high blood pressure changed to HR 1.29 (1.05-1.59) after adjustment of 
blood pressure lowering medication. 
 
**Other risk factors: except of obesity, all risk factors were additionally adjusted for the respectively other risk 
factors (Obesity: number of cigarettes; Smoking: BMI, TC/HDL-C ratio, systolic blood pressure; High TC/HDL-C 
ratio: BMI, systolic blood pressure, number of cigarettes; high blood pressure: BMI, TC/HDL-C ratio, number of 
cigarettes). Obesity was only adjusted for smoking, additional adjustment of blood pressure and cholesterol ratio 
resulted in a HR of 1.57 (1.24-2.00).  
 
CVD-RF, Cardiovascular disease risk factors; PAR, Population Attributable Risk (in %); TC, total cholesterol; 
HDL-C, high density lipoprotein cholesterol 
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Figure A1. Survival curves by number of CVD-RF, for wave 1, male sex and age fixed at 50, 
participants of the Swiss MONICA study, 1983-92, 25-74 years at baseline 
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MONICA: MONItoring of trends and determinants in CArdiovscular disease 
Cardiovascular disease risk factors (CVD-RF) include smoking (current, light and heavy, ≥ 1 cig./d); high blood 
pressure (≥ 140 or ≥ 90); high TC/HDL-C ratio (≥ 5.0); obesity (BMI ≥30 kg/m2) 
TC: total cholesterol; HDL-C: high density lipoprotein cholesterol 
 
 
